Alfred H Moffett
Overview
Explore the profile of Alfred H Moffett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwebke J, Sobel R, Gersten J, Sussman S, Lederman S, Jacobs M, et al.
Clin Infect Dis
. 2021 Sep;
74(11):1979-1985.
PMID: 34467969
Background: Current treatment of vulvovaginal candidiasis (VVC) is largely limited to azole therapy. Ibrexafungerp is a first-in-class triterpenoid antifungal with broad-spectrum anti-Candida fungicidal activity. The objective of this study was...
2.
Bolognese M, Teglbjaerg C, Zanchetta J, Lippuner K, McClung M, Brandi M, et al.
J Clin Densitom
. 2012 Apr;
16(2):147-53.
PMID: 22521543
Denosumab is an approved therapy for postmenopausal women with osteoporosis at high or increased risk for fracture. In the FREEDOM study, denosumab reduced fracture risk and increased bone mineral density...
3.
McClung M, Lewiecki E, Cohen S, Bolognese M, Woodson G, Moffett A, et al.
N Engl J Med
. 2006 Feb;
354(8):821-31.
PMID: 16495394
Background: Receptor activator of nuclear factor-kappaB ligand (RANKL) is essential for osteoclast differentiation, activation, and survival. The fully human monoclonal antibody denosumab (formerly known as AMG 162) binds RANKL with...